Advanced or Metastatic Breast Cancer

DrugDrug NameDrug Description
DB01101CapecitabineA nucleoside metabolic inhibitor indicated to treat different gastrointestinal, including pancreatic cancer, and breast cancer.
DB00947FulvestrantAn estrogen receptor antagonist used to treat HR+ breast cancer that may also be HER2-.
DrugDrug NamePhaseStatusCount
DB11666Buparlisib1Completed1
DB13051CH-51327991Active Not Recruiting1
DB12218Capivasertib1Active Not Recruiting1
DB12021Dinaciclib1Completed1
DB00947Fulvestrant1Active Not Recruiting2
DB01006Letrozole1Completed1
DB01229Paclitaxel1Completed1
DB17284Pelareorep1Completed1
DB09037Pembrolizumab1Completed1
DB11730Ribociclib1Completed1
DB00072Trastuzumab1Active Not Recruiting1
DB00928Azacitidine1 / 2Completed1
DB12218Capivasertib1 / 2Completed1
DB01229Paclitaxel1 / 2Completed2
DB06374Elacestrant2Not Yet Recruiting1
DB00947Fulvestrant2Terminated1
DB15257Milademetan2Terminated1
DB11793Niraparib2Not Yet Recruiting1
DB17391Trastuzumab vedotin2Recruiting1
DB01101Capecitabine3Active Not Recruiting1
DB01590Everolimus3Not Yet Recruiting1
DB00990Exemestane3Not Yet Recruiting1
DB00947Fulvestrant3Not Yet Recruiting1
DB01229Paclitaxel3Active Not Recruiting1
DB14962Trastuzumab deruxtecan3Active Not Recruiting1